Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosis.
Xu Z, Zhang M, Wang W, Zhou S, Yu M, Qiu X, Jiang S, Wang X, Tang C, Li S, Wang CH, Zhu R, Peng WX, Zhao L, Fu X, Patzak A, Persson PB, Zhao L, Mao J, Shu Q, Lai EY, Zhang G.
Xu Z, et al. Among authors: fu x.
Toxicol Appl Pharmacol. 2023 Aug 15;473:116595. doi: 10.1016/j.taap.2023.116595. Epub 2023 Jun 14.
Toxicol Appl Pharmacol. 2023.
PMID: 37328118